Sun Pharmaceutical Industries Gained 3.4 Percent In The Early Trade On Thursday - Dollar Advisory & Financial Services

Breaking

Thursday 22 March 2018

Sun Pharmaceutical Industries Gained 3.4 Percent In The Early Trade On Thursday

Shares of Sun Pharmaceutical Industries gained 3.4 percent in the early trade on Thursday as it has received USFDA approval for its psoriasis drug Ilumya.

Ilumya generically called as tildrakizumab-asmn falls in the category of specialty drugs - medications that treat complex or rare diseases such as cancer, autoimmune disorders, skin conditions among others.

Ilumya is used for the treatment of the most common plaque psoriasis – a chronic immune disease that appears on the skin.

For more information Call us ✆ +91 9111-179961 or Visit Dollar Advisory

No comments:

Post a Comment